AzTrials
AzTrials

BlockNCT06097286

A Comparative Study Between Ultrasound Guided External Oblique Intercostal Plane (EOIP) Block and Erector Spinae Plane (ESP) Block for Postoperative Analgesia in Upper Abdominal Surgeries

A study testing external oblique intercostal plane block and erector spinae plane block in people with Block, run by Ain Shams University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Upper abdominal incisions, such as the oblique subcostal laparotomy, can cause severe pain and can lead to significant respiratory impairment. Erector spinae plane (ESP) block is the deposition of local anaesthetic (LA) in the interfascial plane at the paraspinal region. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Block
What is being tested?
external oblique intercostal plane block and erector spinae plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
No sites listed yet
Study dates
1 Nov 2023to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with American Society of Anesthesiologists physical status (ASA) I and II.
  • Both sex.
  • 20 to 60 years old patients.
  • upper abdominal surgeries.

Who cannot join

  • Refusal of the patient to consent.
  • Patients with ASA status III or IV
  • Patients with bleeding disorders and coagulopathy (INR≥1.6 \& PTT≥50 sec).
  • Infection at the injection site.
  • Allergy to local anesthetics.
  • Patients with ages less than 20 or more than 60
Show all 9Show fewer
  • Patients with pre-existing myopathy or neuropathy.
  • Patients with chronic pain syndromes.
  • Patients with history of long acting opioids or steroids preoperatively.

About this study

Upper abdominal incisions, such as the oblique subcostal laparotomy, can cause severe pain and can lead to significant respiratory impairment.

Erector spinae plane (ESP) block is the deposition of local anaesthetic (LA) in the interfascial plane at the paraspinal region. It provides effective visceral and somatic analgesia.

Read more

External oblique intercostal plane (EOIP) block is a newly described block at which local anaesthetic (LA) is deposited in the interfascial plane deep to external oblique muscle at the sixth intercostal space. It provides blockade of the thoracoabdominal nerves at the level of T6 to T10.

In this study, the investigators compare between ultrasound (US) guided external oblique intercostal plane block and erector spinae plane block, in providing postoperative analgesia for upper abdominal surgeries

Conditions
Block
Being tested
external oblique intercostal plane block, erector spinae plane block
Medical subject headings
Bites and Stings

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • external oblique intercostal plane blockProcedure or surgery

    • EOIP Group (ŋ=25): Patients will receive ultrasound guided External oblique intercostal plane block with 20 ml of LA mixture (10 mL of bupivacaine 0.5%, 5 mL of lidocaine 2% and 5 mL of normal saline to make a total volume of 20 ml.) at the end of procedure, unilaterally or bilaterally according to the surgery.
  • erector spinae plane blockProcedure or surgery

    • ESP Group (ŋ=25): Patients will receive ultrasound guided Erector spinae plane block with 20 ml of LA mixture (10 mL of bupivacaine 0.5%, 5 mL of lidocaine 2% and 5 mL of normal saline to make a total volume of 20 ml.) at the end of procedure, unilaterally or bilaterally according to the surgery.
Study groups in NCT06097286
Study groupRoleWhat they receive
external oblique intercostal plane blockActive comparatorNot described
Receives: Procedure: external oblique intercostal plane block
erector spinae plane blockActive comparatorNot described
Receives: Procedure: erector spinae plane block
control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. amount of total 24 hour pethidine consumption (mg) .

    to measure total 24 hour pethidine consumption postoperatively.

    Measured: 24 hours postoperatively

Secondary outcomes (5)
  1. visual analogue scale (VAS) at rest and movement.

    recorded postoperative immediately and 2, 4, 6, 8, 12, 18 and 24 hours. The Visual Analogue Scale (VAS) measures pain intensity. The visual analogue scale (VAS) consists of a 10 cm line, with two end points representing 0 (no pain) and 10 (pain as bad as it could possibly be).

    Measured: 24 hours postoperatively

  2. mean arterial blood pressure (MAP)

    recorded postoperative immediately and 2, 4, 6, 8, 12, 18 and 24 hours

    Measured: 24 hours postoperatively

  3. heart rate (HR)

    recorded postoperative immediately and 2, 4, 6, 8, 12, 18 and 24 hours

    Measured: 24 hours postoperatively

  4. incidence of postoperative complications (nausea and vomiting)

    recorded postoperative immediately and 2, 4, 6, 8, 12, 18 and 24 hours

    Measured: 24 hours postoperatively

  5. time to start mobilization

    recorded postoperative immediately and 2, 4, 6, 8, 12, 18 and 24 hours

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2023
  2. Study start1 Nov 2023 (estimated)
  3. Primary completion1 Apr 2024 (estimated)
  4. Study completion1 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06097286
Sponsor's protocol ID
MD80/2023
Status last verified
Mar 2023
First submitted
21 Sep 2023
Last updated
24 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing external oblique intercostal plane block and erector spinae plane block in people with Block, run by Ain Shams University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

amount of total 24 hour pethidine consumption (mg) . (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in